SCHEMBL16886167

SCHEMBL16886167

Cc1ccc(COc2cccc(Oc3ccc(-c4nn(C5CCOCC5)c5ncnc(N)c45)cc3F)c2)s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK1A1 P48729 1/20 0.51
▸ CSNK1D P48730 1/20 0.51
▸ CSNK1E P49674 1/20 0.51
▸ SRC P12931 14/20 0.49
▸ PIK3CD O00329 9/20 0.49
▸ PIK3CA P42336 9/20 0.49
▸ PIK3CG P48736 9/20 0.49
▸ EGFR P00533 9/20 0.49
▸ ABL1 P00519 8/20 0.49
▸ HCK P08631 8/20 0.49
▸ KDR P35968 8/20 0.49
▸ PIK3CB P42338 8/20 0.49
▸ MTOR P42345 8/20 0.49
▸ EPHB4 P54760 8/20 0.49
▸ PRKDC P78527 8/20 0.49
▸ PI4KB Q9UBF8 8/20 0.49
▸ LCK P06239 4/20 0.46
▸ CSK P41240 2/20 0.46
▸ BTK Q06187 2/20 0.46
▸ LYN P07948 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16886159 0.93 PIK3CD (0.49) SRCPIK3CDPIK3CAPIK3CGEGFR
SCHEMBL15613519 0.92 CSNK1A1 (0.49) CSNK1A1CSNK1DCSNK1ESRCPIK3CD
SCHEMBL16886160 0.87 BTK (0.53) CSNK1A1CSNK1DCSNK1EBTK
SCHEMBL15613752 0.84 PIK3CD (0.48) SRCPIK3CDPIK3CAPIK3CGEGFR
SCHEMBL16886162 0.84 BTK (0.52) CSNK1A1CSNK1DCSNK1ESRCPIK3CD
SCHEMBL15613542 0.81 BTK (0.56) CSNK1A1CSNK1DCSNK1ESRCEGFR
SCHEMBL16886157 0.81 BTK (0.51) BTK
SCHEMBL16886161 0.80 PIK3CD (0.50) CSNK1A1CSNK1DCSNK1ESRCPIK3CD
SCHEMBL15613750 0.79 BTK (0.52) CSNK1A1CSNK1DCSNK1EBTK
SCHEMBL15613543 0.78 SRC (0.48) CSNK1A1CSNK1DCSNK1ESRCPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9796716-B2 Selective inhibitors of Tec and Src protein kinase families PHARMASCIENCE, INC. (CA) 2017-10-24 — — US disclosed
US-20150191473-A1 PROTEIN KINASE INHIBITORS PHARMASCIENCE, INC. (CA) 2015-07-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150191473-A1 PROTEIN KINASE INHIBITORS TEC, SRC, LCK CSNK1A1 214/4885CSNK1D 587/4885CSNK1E 236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback